| 1 | LYNX1, LYPD1
|
| NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1.
|
| Lyukmanova EN, Shenkarev ZO, Shulepko MA, Mineev KS, D'Hoedt D, Kasheverov IE, Filkin SY, Krivolapova AP, Janickova H, Dolezal V, Dolgikh DA, Arseniev AS, Bertrand D, Tsetlin VI, Kirpichnikov MP.
|
| J Biol Chem 286(12):10618-27. Epub 2011 Jan 20.
2011
|
| 2 | LYPD1
|
| A role for LYNX2 in anxiety-related behavior.
|
| Tekinay AB, Nong Y, Miwa JM, Lieberam I, Ibanez-Tallon I, Greengard P, Heintz N.
|
| Proc Natl Acad Sci U S A 106(11):4477-82. Epub 2009 Feb 25.
2009
|
| 3 | GPR39, LYPD1
|
| GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue.
|
| Egerod KL, Holst B, Petersen PS, Hansen JB, Mulder J, Hškfelt T, Schwartz TW.
|
| Mol Endocrinol 21(7):1685-98. Epub 2007 May 8. 2007
|
| 4 | LYPD1
|
| PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.
|
| Yu DH, Fan W, Liu G, Nguy V, Chatterton JE, Long S, Ke N, Meyhack B, Bruengger A, Brachat A, Wong-Staal F, Li QX.
|
| Exp Cell Res 312(6):865-76. Epub 2006 Jan 17.
2006
|
| 5 | LYNX1, LYPD1
|
| Identification of lynx2, a novel member of the ly-6/neurotoxin superfamily, expressed in neuronal subpopulations during mouse development.
|
| Dessaud E, Salaün D, Gayet O, Chabbert M, deLapeyrière O.
|
| Mol Cell Neurosci 31(2):232-42. Epub 2005 Oct 19.
2006
|